IDXG (OTC)
INTERPACE BIOSCIENCES INC
$1.700000
+0.040000 (+2.41%)
Prev close: $1.660000
Company Information
- Exchange
- OTC Link
- Sector
- Health Services
- Industry
- Services to the Health Industry
- CEO
- Jack E. Stover
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $64.93M
- Employees
- 89
- P/E (TTM)
- 0.00
- P/B (TTM)
- 0.81
- Dividend Yield
- 0.00%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2023 (Q2)
|
$0.09 | $0.00 | +0.0000 | +0.00% |
|
Sep 2022 (Q3)
|
$-3.35 | $-0.26 | -3.0950 | -1,213.73% |
|
Jun 2022 (Q2)
|
$-0.93 | $-0.53 | -0.3996 | -75.34% |
|
Mar 2022 (Q1)
|
$-0.56 | $-0.82 | +0.2560 | +31.37% |
Financial Statements
| Revenues | $36.14M |
| Benefits Costs and Expenses | $32.15M |
| Cost Of Revenue | $13.10M |
| Costs And Expenses | $32.15M |
| Gross Profit | $23.04M |
| Operating Expenses | $18.87M |
| Research and Development | $593.00K |
| Other Operating Expenses | $18.23M |
| Operating Income/Loss | $4.17M |
| Income/Loss From Continuing Operations After Tax | $24.86M |
| Income/Loss From Continuing Operations Before Tax | $4.00M |
| Income/Loss From Discontinued Operations Net Of Tax | -$413.00K |
| Net Income/Loss | $24.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $24.45M |
| Net Income/Loss Available To Common Stockholders, Basic | $24.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $5.37 |
| Diluted Earnings Per Share | $0.88 |
| Basic Average Shares | 29,218,000 |
| Diluted Average Shares | 54,942,000 |
| Assets | $34.55M |
| Current Assets | $10.97M |
| Inventory | $1.09M |
| Other Current Assets | $9.88M |
| Noncurrent Assets | $23.58M |
| Fixed Assets | $1.62M |
| Other Non-current Assets | $21.96M |
| Liabilities | $11.31M |
| Current Liabilities | $4.95M |
| Accounts Payable | $1.56M |
| Wages | $952.00K |
| Other Current Liabilities | $2.44M |
| Noncurrent Liabilities | $6.35M |
| Equity | $23.24M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $23.24M |
| Liabilities And Equity | $34.55M |
| Net Cash Flow From Operating Activities | $4.46M |
| Net Cash Flow From Operating Activities, Continuing | $4.46M |
| Net Cash Flow From Operating Activities, Discontinued | $0.00 |
| Net Cash Flow From Investing Activities | -$353.00K |
| Net Cash Flow From Investing Activities, Continuing | -$353.00K |
| Net Cash Flow From Financing Activities | -$2.10M |
| Net Cash Flow From Financing Activities, Continuing | -$3.06M |
| Net Cash Flow | $1.04M |
| Net Cash Flow, Continuing | $1.04M |
| Net Cash Flow, Discontinued | $0.00 |
| Comprehensive Income/Loss | $24.45M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $24.45M |
| Other Comprehensive Income/Loss | $0.00 |